Elicit makes research software that searches scientific papers and helps people compare their findings. Its cancer examples include finding drug targets and reviewing treatment evidence; researchers still need to check the original studies.
Elicit provides literature search, screening, data extraction and evidence-synthesis workflows. Its pharmaceutical research page demonstrates target research in metastatic neuroendocrine prostate cancer, an osimertinib evidence review in lung cancer and trial-design research in head and neck cancer. These are examples of research support, not evidence that Elicit improves patient outcomes. The company also publishes the AI for Pharma vendor map, which includes Elicit itself.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/